THE ALGOFUNCTIONAL INDEXES FOR HIP AND KNEE OSTEOARTHRITIS

The severity or algofunctional indices for hip and knee osteoarthritis (OA) have been used in Europe for about 10 years. They were validated , then published between 1982 and 1987(1,2) . They are useful mainly a s outcome measures in OA trials, and also for appraising the severity of patient function: a score above 11-12 points after appropriate trea tment indicates surgery. Most patients recruited in OA trials have a s core of 9-11 (SD 23 to 3.8), decreasing about 30 to 40% with the activ e drug. The effect size reaches 1.3 to 1.8. The indices have 2 advanta ges: they are structured separately for hip and for knee OA and the sa me instrument serves as a measure of severity (disability scale) and a s an outcome measurement tool in trials.